Get The Latest Updates From Bio-Based World News

Bio-Based World News latest stories...

$5.8 billion invested by VC’s in bio-based chemicals; focus shifts to disruptive synthetic biology.

Posted by Luke Upton on Jan 9, 2017 4:42:01 PM

$5.8 billion invested by VC’s in bio-based chemicals; focus shifts to disruptive synthetic biology (Pic courtesy of Zymergen Data Science)."VCs have shifted focus this year to commercializing bio-based products that offer improved performance, not just “greener” replacements for petro-based compounds..."

New research has found that synthetic biology start-ups have raised 53% of all VC funding in bio-based materials and chemicals, as venture firms flock to technology platforms such as DNA synthesis-as-a-service. Venture capitalists have pumped in $5.8 billion into bio-based materials and chemicals (BBMC) start-ups since 2010, reflecting the drive for sustainability, performance, and alternatives to petroleum feedstocks. While from 2010 to 2015, the investment focus was on drop-in replacements for established chemicals, in 2016 VCs’ focus has shifted to disruptive synthetic biology (synbio) and conversion technologies, according to Lux Research. Synbio startups attracted over $300 million, accounting for 53% of all VC investment in 2016 (up to October 11th ), and three of the top five deals. Fermentation and catalysis had funding shares of 20% and 16%, respectively.

“VCs in 2016 have taken a step back in the value chain to focus on upstream technology platforms like DNA synthesis-as-a-service and automated genomic engineering and lab equipment,” said Victor Oh, Lux Research Analyst and lead author of the report titled, “Show Me the Money: Where Is Venture Capital Placing Bets in Bio-based?

“Synbio companies are embracing information technology like BioCAD and BioLIMS to create disruption and to integrate new digital genetic tools like CRISPR gene editing,” he added.

$5.8 billion invested by VC’s in bio-based chemicals; focus shifts to disruptive synthetic biology. (Source: Lux Research)

Lux Research ( @LuxResearch )  analysts built a database of companies and investments in the BBMC space. Among their findings: 

  • Synbio poised to grow bigger. The top five VC investments – Zymergen, Gingko Bioworks, Twist Bioscience, Elevance Renewable Science and Bolt Threads – reveal an emphasis on automating synbio. These five have raised $430 million in total, and growth of these platforms should lead to even bigger numbers for the segment in 2017.
  • Spider silk catches fancy. Spider silk’s superior properties over those of conventional fiber materials like nylon and silkworm silk have prompted big deals, like $82 million for Bolt Threads over the last two years. Japan’s Spiber and Germany’s AMSilk have also pulled in big deals, and up-and-comers like Araknitek and Spiber Technologies may be up next.
  • Low oil hits drop-ins, substitutes. Amid low oil prices, VCs have shifted focus this year to commercializing bio-based products that offer improved performance, not just “greener” replacements for petro-based compounds. About 80% of VC investment in 2016 was on improved products, as opposed to only 46% from 2010 to 2015. 

The team at LBio-Based World Quarterly Issue #4ux Research have a complimentary webinar coming up, “The New Face of Bio-based: How Performance Enables Sustainability in Tomorrow’s Products,” on January 17 at 11:00 EST. And data in this articles is taken from a report, titled “Show Me the Money: Where Is Venture Capital Placing Bets in Bio-based?” is part of the Lux Research Bio-based Materials and Chemicals Intelligence service.


 You may also be interested in... 

Synthetic spider silk pioneers receive $50m funding boost.$250m USDA funding pool to help bio-based chemicals and products seeks applications.

Network with leading experts in the bio-based industry by coming along to our next Bio-Based Live Europe event with confirmed speakers from H&M, Tipa, Carlsberg, Unibio, Ikea, BioBTX and many, many more.

Calling all bio-based projects! The Maine Born Global Challenge wants to hear from you!

USDA reserves $100 Million+ in loan guarantee funding for Biosynthetic Technologies.  

Topics: BBWNChemicals